Microsoft word - n003406.doc
MATERIAL SAFETY DATA SHEET
Product Information 803-739-8800 Transportation Emergency 800-451-8346
NAME: 6-Mercaptopurine, monohydrate CAS#: [6112-76-1] CAT#: 3406
HEALTH HAZARD INFORMATION
Irritating to skin, eyes, and respiratory system.
May have harmful effects if inhaled or swallowed.
Avoid prolonged exposure.
Do not breathe vapor.
Exposure to any chemical should limited. To the best of our knowledge, the health hazards of this material have not been fully investigated.
Material is for research and development purposes only.
EXPOSURE CONTROLS/PERSONAL PROTECTION
Avoid all direct contact with product.
Wear protective safety goggles.
Wear chemical-resistant gloves. Wear protective clothing and boots.
Ensure ventilation during use. After contact with skin, wash immediately.
EYE CONTACT: Check for and remove any contact lenses. IMMEDIATELY flush Eyes with running water for at least 15 minutes while keeping eyes open. COLD water may be used. Seek medical attention. SKIN CONTACT: After contact with skin, wash with plenty of water. Gently and thoroughly wash the contaminated skin with running water and non-abrasive soap. COLD water may be used. Cover the irritated skin with an emollient. Seek medical attention. Wash any contaminated clothing before reusing. INHALATION: Remove victim from source of exposure to fresh air. If breathing is difficult administer oxygen. Seek medical attention. INGESTION: Do not induce vomiting. Give water to victim to drink. Seek medical attention.
Phone: (803) 739-8800
Fax: (803) 739-6957 FIRE MEASURES
: carbon dioxide, dry chemical powder, alcohol or polymer foam. Special fire-fighting procedures
: Wear self-contained breathing apparatus and protective
clothing to prevent contact with skin and eyes. Unusual fire and explosion hazards/decomposition of product:
emits toxic fumes under fire
HANDLING AND STORAGE INFORMATION
AVOID PROLONGED USE
AVOID ALL DIRECT CONTACT WITH MATERIAL
Wash thoroughly after handling.
Do not breathe dust or vapor.
Have safety shower and eye wash available.
Do not get in eyes, on skin, on clothing.
Store in a cool, dry, well-ventilated area. Ensure adequate ventilation during use. Use only in a chemical fume hood. Avoid sources of ignition.
ACCIDENTAL RELEASE MEASURES
Steps to be taken if material is released or spilled:
Wear appropriate respirator, rubber boots
and heavy rubber gloves. Scoop up and place in an appropriate container. Ventilate area and
wash spill site after pickup is complete. Wash skin immediately with plenty of water. Absorb on
sand or vermiculite and place in closed containers for disposal.
Dissolve in or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Observe all Federal, State and local laws.
PHYSICAL AND CHEMICAL PROPERTIES
Phone: (803) 739-8800
Fax: (803) 739-6957 REACTIVITY DATA
INCOMPATIBILITIES: strong oxidizing agents. HAZARDOUS DECOMPOSITION PRODUCTS: may evolve carbon monoxide, carbon dioxide, nitrogen oxides, and sulfur oxides.
Irritant May be harmful by ingestion and inhalation. Material is irritating to mucous membranes and upper respiratory tract. RTECS: UP0400000 ACUTE TOXICITY:Oral LD50 1250 mg/kg (mouse) To the best of our knowledge, the toxicological properties of this product have not been fully determined.
The above information is believed to be correct but does not purport to be all-inclusive and shall be used only as a guide. Oakwood shall not be held liable for any damage resulting from handling or from contact with the above product.
Reglement farmaceutische zorg SZVK 2014 Dit Reglement farmaceutische zorg SZVK is de nadere uitwerking van de farmaceutische zorg als bedoeld in artikel 4.7 Farmaceutische zorg van de Algemene verzekeringsvoorwaarden SZVK Basis Pakket en Uitbreiding Basis Pakket. 2.1. Algemeen U hebt recht op geneesmiddelen en dieetpreparaten zoals opgenomen in de verzekeringsvoorwaarden van SZVK.
Clinical and Experimental Allergy, 37, 166–173Continued need of appropriate betalactam-derived skin test reagents for themanagement of allergy to betalactamsM. Blanca , A. Romano , M. J. Torres , P. Demolyz and A. DeWeck‰ÃAllergy Service, Carlos Haya Hospital, M ´alaga, Spain, Department of Internal Medicine and Geriatrics, UCSC-Allergy Unit, Complesso Integrato Columbus, Romeand IRCCS